Breathe Well Live Well
Condition: Rhinoconjunctivitis
Intervention:
Sponsors: Circassia Limited; Circassia Limited; Adiga Life Sciences; Topstone Research
Not yet recruiting – verified September 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma; Tobacco; Waterpipe; Cigarettes
Intervention: Behavioral: TAJ Plus (Adolescent Asthma Action in Jordan) Plus the added class smoke free pledge
Sponsors: University of Technology, Sydney; University of Technology, Sydney; Jordan University of Science and Technology
Completed – verified September 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Mild to Moderate Persistent Asthma
Intervention: Dietary Supplement: Activation Energy Serum
Sponsors: California Allergy and Asthma Medical Group, Inc.; California Allergy and Asthma Medical Group, Inc.
Not yet recruiting – verified September 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Severe IgE-mediated Asthma
Interventions: Drug: Omalizumab; Drug: Budesonide; Drug: Formoterol
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting – verified July 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: SOTB07 200mg; Drug: SOTB07 400mg; Drug: placebo
Sponsors: SK Chemicals Co.,Ltd.; SK Chemicals Co.,Ltd.
Recruiting – verified July 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Albuterol Spiromax; Drug: ProAir HFA; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Not yet recruiting – verified July 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Umeclidinium bromide/Vilanterol; Drug: Placebo ACCUHALER/DISKUS; Drug: Fluticasone propionate/Salmeterol; Drug: Placebo NDPI
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting – verified April 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: WIN-901X dose level 1; Drug: WIN-901X dose level 2; Drug: WIN-901X dose level 3; Drug: Placebo
Sponsors: Whanin Pharmaceutical Company; Whanin Pharmaceutical Company
Recruiting – verified March 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Boehringer Ingelheim presents positive efficacy data for tiotropium in asthma …
The Pharma Letter German family-owned drug major Boehringer Ingelheim presented a new subset of data from the Phase III UniTinA-asthma program relating to its already-marketed drug Spiriva (tiotropium) at the 2013 American Academy of Allergy, Asthma & Immunology … Boehringer Ingelheim drug shows benefits in new asthma trial |
View full post on asthma – Google News
|
Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic …
PR Newswire (press release) SAN ANTONIO, Feb. 23, 2013 /PRNewswire/ — Boehringer Ingelheim presented today a new subset of data from the Phase III UniTinA-asthma™ program at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in San … |
View full post on asthma – Google News